Breast cancer is one of the major malignant tumors that endanger women's health, and it has become the most common cancer in the world. The clinical manifestations of early breast cancer are subtle. As the disease progresses, a hard, painless mass with poor mobility can often be felt, which may be accompanied by skin changes such as orange peel-like changes, and the nipple may be involved and retr
Conditions
Interventions
Gold Standard:Obtain final pathological results or no changes in imaging re-examination within one year
Index test:Artificial Intelligence Breast Auxiliary Diagnosis System (Yizhun DBU)
Sponsors
Affiliated hangzhou first people's hospital, zhejiang university school of medicine
Eligibility
Sex/Gender
Female
Age
40 Years to 69 Years
Inclusion criteria
Inclusion criteria: 1.10000 women aged 40-69 (based on the principle of maximizing benefits under limited resources, the relatively high incidence age group of breast cancer, such as people aged 45-60, can be enriched into the group); 2.Ability to understand research procedures; 3.Voluntarily sign a written informed consent form; 4.There is no typical breast cancer sign visible to the naked eye;
Exclusion criteria
Exclusion criteria: 1. Pregnant, breastfeeding, or planning to conceive; 2. History of Surgery and Radiotherapy for Breast Malignant Tumors; 3.Breast implants; 4. Patients who undergo percutaneous puncture within one year; 5. Cases that have not completed one-year follow-up; 6. Suspected malignant cases without clear pathological results;
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| sensitivity;specificity;Positive predictive value;accuracy;Diagnostic efficiency; | — |
Primary
| Measure | Time frame |
|---|---|
| recall rate;detection rate; | — |
Countries
China
Contacts
Public ContactLingyun Bao
Affiliated hangzhou first people's hospital, zhejiang university school of medicine
Outcome results
None listed